Rami Elghandour, President at NEVRO CORP (NVRO), sold 3,500 shares at $60.00 ($210K) on 2015-11-30, disclosed to the SEC on 2015-12-02.
Scheduled sale ($210k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACLX | SELL | 2025-01-10 | $4.5M | — | Filing → |
| ACLX | SELL | 2025-01-10 | $4.7M | — | Filing → |
| ACLX | SELL | 2025-01-06 | $2.2M | — | Filing → |